Valuation: Boryung Corporation

Market Cap 692B 463M 406M 376M 346M 655M 44.35B 668M 4.49B 1.76B 21.78B 1.74B 1.7B 75.21B P/E 2026 *
10.6x
P/E 2027 * 10.3x
Enterprise Value 692B 463M 406M 376M 346M 655M 44.35B 668M 4.49B 1.76B 21.78B 1.74B 1.7B 75.21B EV / Sales 2026 *
0.65x
EV / Sales 2027 * 0.64x
Free-Float
32.71%
Yield 2026 *
1.95%
Yield 2027 * 1.95%
1 day-3.31%
1 week-3.08%
Current month-2.62%
1 month-5.86%
3 months-16.09%
6 months-6.61%
Current year-9.10%
1 week 8,020
Extreme 8020
8,660
1 month 7,980
Extreme 7980
9,730
Current year 7,910
Extreme 7910
10,800
1 year 7,910
Extreme 7910
10,800
3 years 7,440
Extreme 7440
13,750
5 years 7,440
Extreme 7440
20,200
10 years 5,743.71
Extreme 5743.7069
25,083.33
Manager TitleAgeSince
Chief Executive Officer 41 24/03/2022
Director of Finance/CFO 51 -
Chief Tech/Sci/R&D Officer 55 -
Director TitleAgeSince
Director/Board Member 94 -
Chairman 68 18/05/2014
Director/Board Member 60 24/03/2022
Date Insider Type Main position Quantity % Market Cap.
11/06/25Buy 117,572 0.1355%
11/06/25Buy

Director

400,000 0.4609%
21/05/25Buy

Responsable ventes & marketing

1,000 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-3.31%-3.08%-5.21%+3.67% 477M
-0.73%+0.87%+14.92%+78.11% 48.69B
-2.01%-3.01%+63.83%+113.44% 36.38B
-0.88%-2.16%-3.93%+39.57% 12.19B
-1.69%-0.82%+15.49%+90.65% 12.04B
+2.68%+0.38%+31.49%+122.13% 9.04B
-1.57%-3.25%+17.24%+36.55% 7.09B
-1.13%-0.76%+48.87%-5.59% 7.06B
+0.81%+4.08%+5.51%+240.10% 6.75B
-5.52%-12.48%-22.06%+9.45% 6.1B
Average -1.21%-0.92%+16.61%+72.81% 14.58B
Weighted average by Cap. -1.07%-0.02%+26.32%+85.78%

Financials

2026 *2027 *
Net sales 1,058B 708M 621M 575M 529M 1B 67.79B 1.02B 6.86B 2.69B 33.29B 2.66B 2.6B 115B 1,084B 726M 637M 590M 543M 1.03B 69.49B 1.05B 7.03B 2.76B 34.12B 2.73B 2.67B 118B
Net income 66.2B 44.33M 38.88M 36.01M 33.13M 62.67M 4.24B 63.89M 429M 168M 2.08B 166M 163M 7.2B 68.2B 45.67M 40.06M 37.1M 34.14M 64.57M 4.37B 65.82M 442M 173M 2.15B 171M 168M 7.41B
Net Debt - -
Logo Boryung Corporation
Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures and distributes pharmaceutical products including antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, gastric ulcer drugs, oral antibiotics, anticancer drugs and antihyperlipidemic drugs, among others. The Company distributes its products in domestic and overseas markets.
Employees
1,533
Date Price Change Volume
12/07/26 8,190.00 -3.31% 113,305
10/07/26 ₩8,470.00 +4.96% 114,276
09/07/26 ₩8,070.00 -1.59% 120,281
08/07/26 ₩8,200.00 -2.73% 133,649
07/07/26 ₩8,430.00 +0.36% 143,445
Trader
-
Investor
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
8,190.00KRW
Average target price
14,000.00KRW
Spread / Average Target
+70.94%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A003850 Stock